Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Max Li
AddedFeb 16, 2024
UpdatedMay 31, 2026
Max Li

Max Li

Board Member, BioCeryx

CrunchbaseLinkedInThe Org

Max Li's Career

BioCeryx
BioCeryx

Menlo Park, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Max Li's Career

BioCeryx
BioCeryx
Series A$5M302017Menlo Park, CA, US
Board Member· Board

Leadership at BioCeryx

Thomas MusciThomas MusciCo-Founder
Robert BalogRobert BalogCo-Founder

Similar to BioCeryx

BioFluidicaBioFluidicaSan Diego, CA, USDiagnostic Platformsest. 2006BioFluidicaSan Diego, CA, US · est. 2006

BioFluidica, a San Diego-based biotech firm, develops diagnostic platforms for disease management, specializing in circulating tumor cells.

Series B · $19.2M19
CasprCasprSan Francisco, CA, USDiagnostics, Testingest. 2019CasprSan Francisco, CA, US · est. 2019

Empowering next-gen CRISPR diagnostics through a robust molecular detection platform.

Seed · $2.5M30
FluxergyFluxergyIrvine, CA, USLabtesting, Medicaldiagnosticsest. 2011FluxergyIrvine, CA, US · est. 2011

Fluxergy: Innovating handheld medical diagnostics with multi-modal detection for diverse lab tests.

Series C · $50M88

People Similar to Max Li

Willix HalimWillix HalimCEO · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSong Ji-Ho 'DeanSong Ji-Ho 'DeanBoard Member · KakaoMax SorensonMax SorensonCEO · Ecosil TechnologiesGreg ScottGreg ScottBoard Member · BioPacific InvestorsSanjay MehrotraSanjay MehrotraBoard Member · CDWSebastian GiwaSebastian GiwaCo-Founder · Sylvatica BiotechPaul HermelinPaul HermelinChairman · CapgeminiDavid HsuDavid HsuBoard Member · SolarMax Technology